nicht mehr verfügbar

AP00094CP-N Bcl-2-like 1 control peptide

Search for all "Bcl-2-like 1"

Kurzübersicht

anti Bcl-2-like 1

AP00094CP-N

Produktbeschreibung für Bcl-2-like 1

anti Bcl-2-like 1.
Properties: control peptide
Presentation: Purified

Produktdaten von Bcl-2-like 1

Produkt-Kategorie Control Peptides
Menge 50 µg
Synonyme BCL2L, BCL2L1, BCLX, Bcl-2-like protein 1, Bcl-x, Bcl2-L-1, bcl-xL, bcl-xS
Präsentation Purified
Klonalität Polyclonal
Shipping to Worldwide
PDF datasheet Datenblatt ansehen
Hersteller OriGene Technologies GmbH
Material safety datasheet MSDS for Polyclonal Antibodies (de)

Datenblatt-Auszug

Immunogen
Swiss Prot Num:
Q07817
Anwendung Western blot: It usually blocks the antibody activity completely in Western blot analysis by incubating the peptide with equal volume of antibody for 30 minutes at 37°C.
Background BCL2L1 belongs to the Bcl2 protein family. Bcl2 family members form hetero or homodimers and act as anti or pro apoptotic regulators that are involved in a wide variety of cellular activities. The proteins encoded by this gene are located at the outer mitochondrial membrane, and have been shown to regulate outer mitochondrial membrane channel (VDAC) opening. VDAC regulates mitochondrial membrane potential, and thus controls the production of reactive oxygen species and release of cytochrome C by mitochondria, both of which are the potent inducers of cell apoptosis. Two alternatively spliced transcript variants, which encode distinct isoforms, have been reported. The longer isoform acts as an apoptotic inhibitor and the shorter form acts as an apoptotic activator.
Concentration 0.2 mg/ml
Storage Store the antibody undiluted at -20°C or for long term storage (in aliquots) at -70°C.
Avoid repeated freezing and thawing.
Shelf life: one year from despatch.
Format
Buffer System:
PBS, pH 7.2, containing 0.1% BSA and 0.02% thimerosal
Purity:
purified
State:
Liquid peptide
Purified
Specificity
Specificity:
Control peptide for antibody AP00094PU-N only.

Accessory Products

  • LinkedIn